sulpiride

Small moleculeexperimental

Sulpiride, sold under the brand name Dogmatil among others, is an atypical antipsychotic medication of the benzamide class which is used mainly in the treatment of psychosis associated with schizophrenia and major depressive disorder, and is sometimes used in low dosage to treat anxiety and dysthymia. — Wikipedia

Chemistry & pharmacology

Loading structure…

SMILES

CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
Mol. weight
341.43 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 5-(aminosulfonyl)-n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide
  • 5-(aminosulfonyl)-n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide
  • dogmatyl
  • dogmatyl
  • dolmatil
  • dolmatil
  • n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide
  • n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide
  • n-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
  • n-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
  • sulpirid
  • sulpirid
  • sulpirid
  • sulpirida
  • sulpirida
  • sulpiride
  • sulpiride
  • sulpiride
  • sulpiride
  • sulpiride
  • sulpiride
  • sulpiride
  • sulpiride
  • sulpiride
  • (+-)-sulpiride
  • (+-)-sulpiride
  • sulpiridum
  • sulpiridum
  • sulpitil
  • sulpyrid
  • sulpyrid
  • sulpyrid
  • sursumid

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05208294N/AJan 31, 2022Philipps University of Marburg
NCT05884671N/ASep 23, 2021Donders Centre for Cognitive Neuroimaging, Radboud University
NCT04583111Phase 4Mar 1, 2020Jiao Tong University
NCT02435095Phase 4May 1, 2015RWTH Aachen University
NCT02374567Phase 3Jan 1, 2015Gottfried Wilhelm Leibniz Universität Hannover
NCT02307396Phase 4Nov 1, 2014Technical University of Munich
NCT02749747Phase 3Jun 1, 2014Federal University of Rio Grande do Sul
NCT01896349N/AApr 1, 2013Federal University of Rio Grande do Sul
NCT01777685N/AJan 1, 2013Damanhour University
NCT00280501N/AAug 1, 2005University of Vienna
NCT00654576Phase 4Feb 1, 2005Capital Medical University, Central South University, Chongqing Medical University, Guangzhou Medical University, Henan Medical University, Hunan Mental Hospital, Jiangxi Mental Hospital, Jiao Tong University, Nanjing Medical University, Sichuan University
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (19)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Federal University of Rio Grande do SulAcademic/Hospital2222013
Jiao Tong UniversityAcademic/Hospital2112005
Capital Medical UniversityAcademic/Hospital1012005
Central South UniversityAcademic/Hospital1112005
Chongqing Medical UniversityAcademic/Hospital1012005
Damanhour UniversityAcademic/Hospital1112013
Donders Centre for Cognitive NeuroimagingAcademic/Hospital1112021
Gottfried Wilhelm Leibniz Universität HannoverAcademic/Hospital1112015
Guangzhou Medical UniversityAcademic/Hospital1012005
Henan Medical UniversityAcademic/Hospital1012005
Hunan Mental HospitalAcademic/Hospital1012005
Jiangxi Mental HospitalAcademic/Hospital1012005
Nanjing Medical UniversityAcademic/Hospital1012005
Philipps University of MarburgAcademic/Hospital1112022
Radboud UniversityAcademic/Hospital1012021
RWTH Aachen UniversityAcademic/Hospital1112015
Sichuan UniversityAcademic/Hospital1012005
Technical University of MunichAcademic/Hospital1112014
University of ViennaAcademic/Hospital1112005
19 organizations
Page 1 / 1